| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.75B | — | +14.2% |
| Cost of Revenue | $711.2M | — | +9.3% |
| Gross Profit | $1.04B | — | +17.8% |
| R&D Expense | $295.8M | — | +10.3% |
| SG&A Expense | $314.8M | — | +11.0% |
| Operating Income | $431.7M | — | +29.7% |
| Pre-tax Income | $472.5M | — | +21.4% |
| Income Tax | $67.5M | — | +19.8% |
| Net Income | $405.1M | — | +21.7% |
| EPS (Basic) | $2.10 | — | +21.4% |
| EPS (Diluted) | $2.09 | — | +21.5% |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.29B | +0.5% | +5.3% |
| Accounts Receivable | $941.0M | -24.9% | +19.5% |
| Inventory | $1.85B | +4.4% | +17.0% |
| Current Assets | $6.00B | -4.0% | +10.1% |
| Total Assets | $10.95B | -0.4% | +11.9% |
| Current Liabilities | $1.38B | -20.0% |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $536.0M | — | +27.4% |
| Capital Expenditures | $66.6M | — | +66.3% |
| Investing Cash Flow | -$252.4M | — | -90.3% |
| Financing Cash Flow | -$260.1M | — | -27.0% |
| Free Cash Flow | $469.4M | — | +23.3% |
| +3.4% |
| Stockholders' Equity | $9.27B | +3.3% | +13.3% |